BioInnovation Solutions, formerly Pathogenica, and Enzymatics are developing a rapid Ebola diagnostic and have validated it on patient samples in Nigeria.

NEW YORK (GenomeWeb) – Pathogen sequencing company Pathogenica has moved to Lausanne, Switzerland and rebranded itself as BioInnovation Solutions, Clinical Sequencing News has learned.

NEW YORK (GenomeWeb) — A study by researchers from two Dutch medical centers and pathogen sequencing company Pathogenica has found that the company's HAI BioDetection kit compared well with the standard method used to type multi-drug resistantEscherichia coli.

Last week, Pathogenica announced that it achieved the CE mark under the European Directive on In Vitro Diagnostic Medical Devices for its HAI BioDetection kit, a sequencing-based assay that uses Life Technologies' Ion Torrent PGM to detect 12 pathogenic bacterial species

NEW YORK (GenomeWeb News) – Pathogenica said today that it will co-market with Illumina a new version of its HAI BioDetection kit on Illumina's MiSeq desktop sequencing system in the Asia Pacific region.

NEW YORK (GenomeWeb News) – Two hospitals in the Netherlands — the University Medical Center Groningen and Amphia Hospital — plan to evaluate and adopt Pathogenica's next-generation sequencing-based HAI BioDetection Kit in the surveillance and monitoring of infectious bacteria, the company said t

NEW YORK (GenomeWeb News) – Targeted Genomics announced today a partnership to distribute Pathogenica's HAI BioDetection kit in Australia and New Zealand.

NEW YORK (GenomeWeb News) – Takara Bio said Monday that it has signed an agreement to offer Pathogenica's HAI BioDetection Kit in Japan as part of its sequencing services.

Pathogen sequencing company Pathogenica has developed a targeted sequencing-based kit for hospital-acquired infections that it said will help drive clinical adoption of sequencing for monitoring hospital outbreaks.

NEW YORK (GenomeWeb News) – Pathogenica today announced that it has signed a co-marketing pact with Life Technologies for sequencing-based diagnostic tests targeting hospital-acquired infections.


Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.